| Report ID |
138194 |
| Drug Identification Number |
02378426 |
| Brand name |
LOVENOX |
| Common or Proper name |
Lovenox |
| Company Name |
SANOFI-AVENTIS CANADA INC |
| Market Status |
MARKETED |
| Active Ingredient(s) |
ENOXAPARIN SODIUM |
| Strength(s) |
60MG |
| Dosage form(s) |
SOLUTION |
| Route of administration |
SUBCUTANEOUS
SUBCUTANEOUS |
| Packaging size |
10 |
| ATC code |
B01AB |
| ATC description |
ANTITHROMBOTIC AGENTS |
| Reason for shortage |
Other (Please describe in comments) |
| Anticipated start date |
2021-12-20 |
| Actual start date |
|
| Estimated end date |
2022-01-31 |
| Actual end date |
2022-01-13 |
| Shortage status |
Resolved |
| Updated date |
2022-01-14 |
| Company comments |
Transportation delay and overselling is leading to a limited supply of product. Allocation will be kept in place to mitigate the anticipated shortage. |
| Health Canada comments |
|
| Tier 3 Status |
No |
| Company contact information |
email: CAINTERNET@sanofi.com
Telephone: 1-800-265-7927 |
